NYSE · AGL

agilon health, Inc.

$98.43 +$0.43 (+0.44%) 1D Market open

Key Metrics

$1.64B
Market cap
P/E · TTM
$5.82B
Revenue · TTM
−$354.54M
Net income
EPS · TTM $-21.47
Dividend yield
Free cash flow −$62.54M
Beta · 1Y 2.82
EBITDA · TTM −$343.96M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 21
    A material event was filed (Form 8-K).

    8-K - agilon health, inc. (0001831097) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +117.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Apr 6
    The stock moved +30.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 6
  • Mar 31
    From its Jan 29 high, the share price fell 63%.

    Peak close $21.55 on Jan 29; trough close $7.91 on Mar 31. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -63%

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.64B
Enterprise value$1.53B
Shares outstanding16.7M
52-wk range$0.51 – $133.04
Avg volume · 20D3.5M
Net cash $109.96M
Book value / share$10.98
IndustryServices-Misc Health & Allied Services, Nec
ExchangeNYSE
About agilon health, Inc.
IPO dateApr 15, 2021
Employees856

Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.28
P/FCF
EV/EBITDA
EV/Sales0.26
Graham №

Profitability

Gross
Operating -6.4%
Net -6.1%
FCF -1.1%
ROE / ROIC -108.7% · -522.6%

Financial Health

Current ratio1.04
Quick ratio
Debt / equity0.17
Debt / EBITDA -0.09
Net cash $109.96M
Working capital$48.85M

Cash Flow · TTM

Operating CF −$50.05M
Capex −$12.49M
Free cash flow −$62.54M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

2.0
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings